Full Text View
Tabular View
No Study Results Posted
Related Studies
Dabigatran Etexilate in Patients With Mechanical Heart Valves
This study is ongoing, but not recruiting participants.
Study NCT01452347   Information provided by Boehringer Ingelheim Pharmaceuticals

First Received on October 11, 2011.   Last Updated on February 4, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Heart Valve Diseases
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Interventions listed in this trial
warfarin 1mg
dabigatran etexilate low dose
warfarin 5mg
dabigatran etexilate high dose
warfarin 3mg
Additional drug interventions recognized in this trial
Warfarin
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services